Distinct glucose lowering and beta cell protective effects of vanadium and food restriction in streptozotocin-diabetes

European Journal of Endocrinology

Volumn 141, Issue 5, 1999, Pages 546-554

  Cam, Margaret C ^a   Rodrigues, Brian ^a   McNeill, John H ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; STREPTOZOCIN; VANADIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DIET RESTRICTION; DRUG EFFECT; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN RELEASE; MALE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES;

EID: 0032699589     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1410546     Document Type: Article

References (44)

1. Blondel O, Bailbe D & Portha B. In vivo insulin resistance in streptozotocin-diabetic rats - evidence for reversal following oral vanadate treatment. Diabetologia 32 185-190.
2. Brichard SM, Okitolonda W & Henquin JC. Long term improvement of glucose homeostasis by vanadate treatment in diabetic rats. Endocrinology 1988 123 2048-2053.
3. Cam MC, Pederson RA, Brownsey RW & McNeill JH. Long-term effectiveness of oral vanadyl sulphate in streptozotocin-diabetic rats. Diabetologia 1993 36 218-224.
4. Cam MC, Faun J & McNeill JH. Concentration-dependent glucose-lowering effects of oral vanadyl are maintained following treatment withdrawal in streptozotocin-diabetic rats. Metabolism 1995 44 332-339.
5. Pederson RA, Ramanadham S, Buchan AMJ & McNeill JH. Long-term effects of vanadyl treatment on streptozotocin-induced diabetes in rats. Diabetes 1989 28 1390-1395.
6. Cam MC, Li WM & McNeill JH. Partial preservation of pancreatic β-cells by vanadium: evidence for a mechanism of chronic amelioration of diabetes. Metabolism 1997 46 769-778.
7. Meyerovitch J, Shechter Y & Amir S. Vanadate stimulates in vivo glucose uptake in brain and arrests food intake and body weight gain in rats. Physiology and Behavior 1989 45 1113-1116.
8. Malabu UH, Dryden S, McCarthy D, Kilpatrick A & Williams G. Effects of chronic vanadate administration in the STZ-induced diabetic rat. The anti-hyperglycemic action of vanadate is attributable entirely to its suppression of feeding. Diabetes 1994 439-15.
9. Domingo JL, Gomez M, Sanchez DJ, Llobet JM, Corbella J & Keen CL. Normalization of hyperglycemia by vanadate or vanadyl treatment in diabetic rats: pharmacological and toxicological aspects. Trace Elements in Medicine 1994 11 16-22.
10. Cameron-Smith D, Collier GR & O'Dea K. Reduction in hyperglycemia by mild food restriction in streptozotocin-induced diabetic rats improves insulin sensitivity. Hormone and Metabolic Research 1994 26 316-321.
11. Chu KU, Ishizuka J, Poston GJ, Townsend CM, Greeley GH, Yu BP et al. Change in endocrine pancreatic function in short-term diet restriction. Nutrition 1991 7 425-429.
12. Escriva F, Rodriguez C, Cacho J, Alvarez C, Portha B & Pascual-Leone AM. Glucose utilization and insulin action in adult rats submitted to prolonged food restriction. American Journal of Physiology 1992 263 E1-E7.
13. Picarelblanchot F, Alvarez C, Bailbe D, Pascualleone AM & Portha B. Changes in insulin action and insulin secretion in the rat after dietary restriction early in life - influence of food restriction versus low-protein food restriction. Metabolism 1995 44 1519-1526.
14. Linn T, Geyer R, Prassek S & Laube H. Effect of dietary protein intake on insulin secretion and glucose metabolism in insulin-dependent diabetes mellitus. Journal of Clinical Endocrinology and Metabolism 1996 81 3938-3943.
15. Cam MC & McNeill JH. A sensitive radioimmunoassay optimized for reproducible measurement of rat plasma insulin. Journal of Pharmacological and Toxicological Methods 1996 35 111-119.
16. Mowry RW, Longley GB & Emmel VM. Only aldehyde-fuchsin made from pararosanilin stains pancreatic β-cell granules and elastic fibers in unoxidized microsection: problems caused by mislabeling of certain basic fuchsins. Stain Technology 1980 55 91-103.
17. Mongold JJ, Cros GH, Vian L, Tep A, Ramanadham S, Siou G et al. Toxicological aspects of vanadyl sulphate on diabetic rats: effects on vanadium levels and pancreatic β-cell morphology. Pharmacology and Toxicology 1990 67 192-198.
18. Dai, S, Thompson KH, Vera E & McNeill JH. Toxicity studies on one-year treatment of non-diabetic and streptozotocin-diabetic rats with vanadyl sulphate. Pharmacology and Toxicology 1994 75 265-273.
19. Elliott JF. New approaches to preventing and treating Type 1 diabetes: discovering a method to preserve β cell mass after diagnosis should remain a key research focus. Canadian Journal of Diabetes Care 1998 22 S24-S30.
20. Thulesen J, Orskov C, Holst JJ, Seier S & Poulsen S. Short term insulin treatment prevents the diabetogenic action of streptozotocin in rats. Endocrinology 1997 138 62-68.
21. Eizirik DL, Strandell E & Sandler S. Culture of mouse pancreatic islets in different glucose concentrations modifies β cell sensitivity to streptozotocin. Diabetologia 1988 31 168-174.
22. Ar'Rajab A & Ahren B. Long-term diabetogenic effect of streptozotocin in rats. Pancreas 1993 8 51-57.
23. Schnell O, Eisfelder B, Standl E & Ziegler AG. High-dose intravenous insulin infusion versus intensive insulin treatment in newly diagnosed IDDM. Diabetes 1997 46 1607-1611.
24. Shah SC, Malone JI & Simpson NE. A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus. New England Journal of Medicine 1989 320 550-554.
25. Bjork E, Berne C, Kampe O, Wibell L, Oskarsson P & Karlsson FA. Diazoxide treatment at onset preserves residual insulin secretion in adults with autoimmune diabetes. Diabetes 1996 45 1427-1431.
26. Vlahos WD, Seemayer TA & Yale JF. Diabetes prevention in BB rats by inhibition of endogenous insulin secretion. Metabolism 1991 40825-829.
27. Leahy JL, Bumbalo LM & Chen C. Diazoxide causes recovery of β-cell glucose responsiveness in 90% pancreatectomized diabetic rats. Diabetes 1994 43 173-179.
28. Junod A, Lambert AE, Stauffacher W & Renold AE. Diabetogenic action of streptozotocin: relationship of dose to metabolic response. Journal of Clinical Investigation 1969 48 2129-2139.
29. Leahy JL, Bumbalo LM & Chen C. Beta-cell hypersensitivity for glucose precedes loss of glucose-induced insulin secretion in 90% pancreatectomized rats. Diabetologia 1993 36 1238-1244.
30. Brichard SM, Pottier AM & Henquin JC. Long-term improvement of glucose homeostasis by vanadate in obese hyperinsulinemic fa/fa rats. Endocrinology 1989 124 2510-2516.
31. Bhanot S, Bryer-Ash M, Cheung A & McNeill JH. Bis(maltolato)oxovanadium(IV) attenuates hyperinsulinemia and hypertension in spontaneously hypertensive rats. Diabetes 1994 43 857-861.
32. Bhanot S, McNeill JH & Bryer-Ash M. Vanadyl sulfate prevents fructose-induced hyperinsulinemia and hypertension in rats. Hypertension 1994 23 308-312.
33. Brichard SM, Bailey CJ & Henquin JC. Marked improvement of glucose homeostasis in diabetic ob/ob mice given oral vanadate. Diabetes 1990 39 1326-1332.
34. Fagin JA, Ikejiri K & Levin SR. Insulinotropic effects of vanadate. Diabetes 1987 36 1448-1452.
35. Zhang A, Gao ZY, Gilon P, Nenquin M, Drews G & Henquin JC. Vanadate stimulation of insulin release in normal mouse islets. Journal of Biological Chemistry 1991 266 21649-21656.
36. Voss C, Herrmann I, Hartmann K & Zuhlke H. In vitro effect of vanadate on content, secretion and biosynthesis of insulin in isolated islets of normal Wistar rats. Experimental and Clinical Endocrinology 1992 99 159-163.
37. Ozcelikay AT, Becker DJ, Ongemba LN, Pettier AM, Henquin JC & Brichard SM. Improvement of glucose and lipid metabolism in diabetic rats treated with molybdate. American Journal of Physiology 1996 270 E344-E352.
38. Becker DJ, Reul B, Ozcelikay AT, Buchet JP, Henquin JC & Brichard SM. Oral selenate improves glucose homeostasis and partly reverses abnormal expression of liver glycolytic and gluconeogenic enzymes in diabetic rats. Diabetologin 1996 39 3-11.
39. Barbera A, Fernandez-Alvarez J, Truc A. Gomis R & Guinovart JJ. Effects of tungstate in neonatally streptozotocin-induced diabetic rats: mechanism leading to normalization of glycemia. Diabetologia 1997 40 143-149.
40. Bendayan M & Gringas D. Effect of vanadate administration on blood glucose and insulin levels as well as on the exocrine pancreatic function in streptozotocin-diabetic rats. Diabetologia 1989 32 561-567.
41. Yuen, VG, Orvig C & McNeill JH. Effects of bis(maltolato)oxovanadium(IV) are distinct from food restriction in STZ-diabetic rats. American Journal of Physiology 1997 272 E30-E35.
42. Yuen VG, Orvig C & McNeill JH. Comparison of the glucose-lowering properties of vanadyl sulfate and bis(maltolato)oxovanadium(IV) following acute and chronic administration. Canadian Journal of Physiology and Pharmacology 1994 73 55-64.
43. McCulloch DK, Koerker DJ, Kahn SE, Bonner-Weir S & Palmer JP. Correlations of in vivo beta-cell function tests with beta-cell mass and pancreatic insulin content in streptozotocin-administered baboons. Diabetes 1991 40 673-679.
44. McKibbin PE, McCarthy HD, Shaw P & Williams G. Insulin deficiency is a specific stimulus to hypothalamic neuropeptide Y: a comparison of the effects of insulin replacement and food restriction in streptozocin-diabetic rats. Peptides 1992 13 721-727.